Recent insider selling at Donaldson Company, occurring below current price, is seen as a negative signal. Despite some insider buying, the long-term outlook isn't positive. However, company's profitability and growth offset some concerns. Insider ownership suggests alignment with the company, but their selling discourages rushing to buy the stock.
EPS growth outshines the 5% yearly share price gain, indicating market caution towards the stock. The company's TSR provides a fuller picture for dividend-paying stocks. The gain surpasses the average annual return of 7% over five years, hinting at potential company improvement.
Investors' bullish stance despite high P/E ratio and poor earnings outlook could risk investments. Potential investors might be overpaying, and predicted earnings may not sustain positive sentiment, impacting share price.
The company's substantial ROE and earnings growth suggests successful reinvestment of profits. With the predicted decrease in the payout ratio, the company is likely to further reinvest, maintaining the current growth rate.
$遊戲驛站(GME.US)$initiated at overweight by Barclays, announced target price at $215.00. $Tradeweb Markets(TW.US)$initiated at overweight by Barclays, announced targe price at $89.00. $Pinterest(PINS.US)$was upgraded by Wells Fargo from equal-weight to overweight, increased target price from $23.00 to $34.00. $貝哲房屋(BZH.US)$was upgraded by Wedbush from neutral to outperform. $優步(UBER.US)$was downgraded by Daiwa Capi...
唐納森股票討論區
$Tradeweb Markets(TW.US)$ initiated at overweight by Barclays, announced targe price at $89.00.
$Pinterest(PINS.US)$ was upgraded by Wells Fargo from equal-weight to overweight, increased target price from $23.00 to $34.00.
$貝哲房屋(BZH.US)$ was upgraded by Wedbush from neutral to outperform.
$優步(UBER.US)$ was downgraded by Daiwa Capi...
2023Q1營收增長11.35%,營業利潤增長11%,淨利潤增長13%。
目前市盈率23,相對於利潤增速來說吸引力不大。
In reaction to earnings/guidance:
• $ChargePoint(CHPT.US)$ +2.8%, $Designer Brands(DBI.US)$ +1.8%, $唐納森(DCI.US)$ +0.7%
Other news:
• $Cepton(CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics(SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma(MREO.US)$ +6.7% (sends letter to Rubric Capital...
• $維多利亞的秘密(VSCO.US)$ +10.4% (In reaction to earnings)
• $賽富時(CRM.US)$ +9.0% (In reaction to earnings)
• $Navigator(NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $微博(WB.US)$ +4.7% (In reaction to earnings)
• $CAE Inc(CAE.US)$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics(AXSM.US)$ +3.1% (Late-Breaking Presentations of P...
暫無評論